Hgi Capital Management, LLC Pfizer Inc Transaction History

Hgi Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 04, 2021	SELL	$33.47 - $42.56 $306,986 - $390,360	-9,172 Closed	0 $0
Q3 2020 Oct 29, 2020	SELL	$31.75 - $37.25 $26,289 - $30,843	-828 Reduced 8.28%	9,172 $337,000
Q2 2019 Jul 26, 2019	SELL	$36.98 - $41.52 $369,799 - $415,200	-10,000 Reduced 50.0%	10,000 $433,000
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $94,137 - $114,183	-2,731 Reduced 12.01%	20,000 $881,000
Q2 2018 Nov 07, 2018	BUY	$32.98 - $35.16 $749,668 - $799,221	22,731 New	22,731 $825,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Hgi Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Hgi Capital Management, LLC with notifications on news.